期刊文献+

Bcl-2和Hrk及细胞周期素E在胃癌组织中的表达及其意义 被引量:6

Study of the Expression and Biological Significance of Bcl-2,Hrk and Cyclin E in Gastric Cancer
下载PDF
导出
摘要 目的探讨凋亡抑制蛋白Bcl-2、凋亡促进蛋白Hrk及细胞周期素E(Cyclin E)在胃癌中的表达及其意义。方法采用免疫组化(S-P)法检测58例胃癌患者的癌组织蜡块标本及正常癌旁组织中Bcl-2蛋白、Hrk蛋白及Cyclin E蛋白的表达情况。结果 Bcl-2蛋白在胃癌组织中阳性表达38例,阳性率为65.5%,癌旁组织中阳性表达14例,阳性率为24.1%,两种组织中Bcl-2蛋白阳性率比较,差异有统计学意义(χ2=20.077,P<0.05)。不同肿瘤分化程度、临床分期及有无淋巴转移胃癌患者中Bcl-2蛋白阳性率比较,差异均有统计学意义(P<0.05);不同年龄、肿瘤直径、Borrmann分型、浸润深度胃癌患者中Bcl-2蛋白阳性率比较,差异均无统计学意义(P>0.05)。Hrk蛋白在胃癌组织中阳性表达12例,阳性率为20.7%,癌旁组织中阳性表达36例,阳性率为62.1%,两种组织中Hrk蛋白阳性率比较,差异有统计学意义(χ2=20.471,P<0.05)。Cyclin E蛋白在胃癌组织中阳性表达34例,阳性率为58.6%,癌旁组织中阳性表达11例,阳性率为18.9%,两种组织中Cyclin E蛋白阳性率比较,差异有统计学意义(χ2=19.206,P<0.05)。Spearman相关分析表明,Bcl-2蛋白与Hrk蛋白呈负相关(r=-0.286,P<0.05),与Cy-clin E蛋白呈正相关(r=0.749,P<0.05)。结论胃癌的形成与多种蛋白的相互作用及基因水平上正负信号转导、调控密切相关,凋亡抑制蛋白Bcl-2、凋亡促进蛋白Hrk及Cyclin E共同参与胃癌的发生发展。 Objective To study the expression and significance of inhibitor of apoptosis protein Bcl -2, apoptosis promote protein Hrk and cell cycle element Cyclin E in gastric cancer. Methods The expressions of Bcl -2, Hrk and Cyclin E in the samples of gastric cancer and adjacent normal tissues of 58 patients with gastric cancer were detected by S - P meth- od. Results Bcl -2 protein had positive expression in 38 cases of gastric cancer tissues with a positive rate of 65.5%, and had positive expression in 14 cases of adjacent normal tissues with a positive rate of 24. 1%. The difference of positive rate between the two tissues showed statistically significant difference ( X2 = 20. 077, P 〈 0. 05 ) . Patients with different cancer differentiation lev- els, clinicM stages and whether having lymph node metastases or not showed statistically significant difference in the positive rate of Bcl - 2 protein (P 〈 0. 05 ) . Patients with different age, tumor diameter, Borrmann type and infiltration depth showed no sta- tistically significant difference in the positive rate of Bcl -2 protein (P 〉 0. 05 ) . Hrk protein had positive expression in 12 cases of gastric cancer tissues with a positive rate of 20. 7%, and had positive expression in 36 cases of adjacent normal tissues with a positive rate of 62. 1%. The difference of positive rate between the two tissues showed statistically significant difference ( x2 = 20. 471, P 〈0. 05) . Cyclin E protein had positive expression in 34 cases of gastric cancer tissues with a positive rate of 58.6%, and had positive expression in 11 cases of adjacent normal tissues with a positive rate of 18.9%. The difference of positive rate be- tween the two tissues showed statistically significant difference ( X2 = 19. 206, P 〈0. 05) . Spearman correlation analysis showed that Bcl - 2 protein was negatively correlated with Hrk protein ( r = - 0. 286, P 〈 0. 05 ), and was positively correlated with Cy- clin E protein ( r = 0. 749, P 〈 O. 05 ) . Conclusion The pathogenesis of gastric cancer is closely related to the mutual effect of various proteins and positive and negative signal transduction and regulation in genetic level. Inhibitor of apoptosis protein Bcl - 2, apoptosis promote protein Hrk and Cyclin E are involved in the pathogenesis and development of gastric cancer.
出处 《中国全科医学》 CAS CSCD 北大核心 2012年第24期2790-2793,共4页 Chinese General Practice
基金 新疆生产建设兵团卫生科技计划基金项目(2011年第16号)
关键词 细胞凋亡 基因 BCL-2 Hrk基因 细胞周期蛋白E 胃肿瘤 Apoptosis Genes, Bcl - 2 Genes, Hrk Cyclin E Stomach neoplasms
  • 相关文献

参考文献12

  • 1凌霄华,庄丽维,胡成乙,洪钰,于欣.早期胃癌胃微血管形态变化及Bcl-2和M2-丙酮酸激酶的表达特点研究[J].中国全科医学,2010,13(30):3389-3391. 被引量:7
  • 2曾慈梅,徐海霞.Bcl-2和Bax在非小细胞肺癌中的表达与MVD的相关性研究[J].海南医学院学报,2009,15(10):1208-1211. 被引量:3
  • 3Gross M,Dexter TM.Growth factors in development,transformation,and tumorigenesis[J].Cell,1991,64(2):271-280.
  • 4Altieri DC.The molecular basis and potential role of survivin in cancer diagnosis and therapy[J].Trends Mol Med,2001,7(1):542-547.
  • 5Conway EM,Pollefeyt S,Steiner-Mosonyi M,et al.Deficiency of survivin in transgenic mice exacerbates Fas induced apoptosis via mitochondrial pathways[J].Gastroenterology,2002,123(1):619-631.
  • 6Inohara N,Ding L,Chen S,et al.Harakiri,a novel regulator of cell death,encodes a protein that activates apoptosis and interacts selectively with survival-promoting proteins Bcl-2 and Bcl-X(L)[J].EMBO J,1997,16(1):1686-1694.
  • 7Kalinec GM,Fernandez-Zapico ME,Urrutia R,et al.Pivotal role of Harakiri in the induction and prevention of gentamicin-induced hearing loss[J].PNAS,2005,102(1):16019-16024.
  • 8Sunayama J,Ando Y,Itoh N,et al.Physical and functional interaction between BH3-only protein Hrk and mitochondrial pore-forming protein p32[J].Cell Death Differ,2004,11(1):771-781.
  • 9Gong J,Traganos F,Darzynkiewicz Z.Threshold expression of cyclin E but not D type cyclins characterizes normal and tumor cells entering S phase[J].Cell Prolif,1995,28(1):337-346.
  • 10Resnitzky D,Gossen M,Bujard H,et al.Acceleration of the G1/S phase transition by expression of cyclin D1 and E with an inducible system[J].Mol Cell Biol,1994,14(1):1669-1679.

二级参考文献18

  • 1许静洪,魏晓丽,张晓华.胃癌相关基因表达与其生物学行为关系研究[J].山东医药,2004,44(34):8-9. 被引量:5
  • 2陈磊,房殿春,李向红,彭贵勇,杨仕明,郭德玉.放大色素内镜诊断早期胃癌及其癌前病变[J].解放军医学杂志,2005,30(9):807-809. 被引量:23
  • 3卢雪峰,王尊松,李永昌,付金栋.放大内镜联合端粒酶逆转录酶对胃癌前病变的诊断价值[J].中华内科杂志,2006,45(1):17-20. 被引量:8
  • 4卢雪峰,付金栋,王尊松,姜大磊,李延青.胃小凹及微血管形态变化对胃良恶性溃疡的诊断价值[J].中华消化内镜杂志,2006,23(6):430-432. 被引量:12
  • 5Kroemer G, Petit P, Zamzami N, et al. The biochemistry of programmed cell death[J]. FASEB J, 1995, 9:1277- 1287.
  • 6Wong CW, Lee A, Shientag L. Apoptosis: an early event in metastatic inefficiency[J]. Cancer Research, 2001, 61 ( 1 ):333-338.
  • 7Toomey D, Smyth G, Condron C, et al. Immune function, telomerase, and angiogenesis in patients with primary, operable nonsmall cell lung carcinoma: tumor size and lymph node status remain the most important prognostic features [ J]. Cancer, 2001,92:2648-2657.
  • 8Lai RS, Wang JS, Hsu HK, et al. Prognostic evaluation of the expression of p53 and bcl-2 oncoproteins in patients with surgically resected non-small cell lung cancer[J].Jpn Clin Oncol, 2002,32:393-297.
  • 9Ludovini V, Gregorc V, Pistola L, et al. Vascular endothelial growth factor, p53, Rb, Bcl-2 expression and response to chemotherapy in advanced non-small cell lung cancer[ J]. Lung Cancer, 2004,46:77-85.
  • 10Uchida S, Shimada Y, Watanabe G, et al. In oesophageal squamous cell carcinoma vascular endothelial growth factor is associated with p53 mutation, advanced stage and poor prognosis[ J]. Br J Cancer, 1998, 77:1704-1709.

共引文献8

同被引文献74

引证文献6

二级引证文献85

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部